Drugmaker Mylan Inc said on Friday it plans to enter the Indian commercial market with its own prescription drugs in the next 12 months, the chairman told reporters on Friday.
"Over the next 6-12 months we will come out with our complete launch plan. The anti-retro viral opportunity will be very big for us," Chairman and CEO Robert J Coury said.Mylan also announced the rebranding of its Hyderabad unit Matrix Laboratories to Mylan. 
